Tuesday, May 09, 2017 11:18:22 PM
The sticking point with INVIVO is that this is still dead money for fourteen more months due to approvals.
In the latest corporate filing they state they cannot manufacture the scaffold on a large scale and that they will have to find another company to do that. Therefore they will loose control of certain aspects.
Also your numbers of patience seem rather generous. What year do you believe they will be able to service thousands of patients
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM